BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32923153)

  • 1. Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma.
    Dufresne A; Lesluyes T; Ménétrier-Caux C; Brahmi M; Darbo E; Toulmonde M; Italiano A; Mir O; Le Cesne A; Le Guellec S; Valentin T; Chevreau C; Bonvalot S; Robin YM; Coindre JM; Caux C; Blay JY; Chibon F
    Oncoimmunology; 2020 Jul; 9(1):1792036. PubMed ID: 32923153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
    Brahmi M; Lesluyes T; Dufresne A; Toulmonde M; Italiano A; Mir O; Le Cesne A; Valentin T; Chevreau C; Bonvalot S; Penel N; Coindre JM; Le Guellec S; Le Loarer F; Karanian M; Blay JY; Chibon F
    ESMO Open; 2021 Feb; 6(1):100037. PubMed ID: 33524869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets.
    Merlini A; Rabino M; Brusco S; Pavese V; Masci D; Sangiolo D; Bironzo P; Scagliotti GV; Novello S; D'Ambrosio L
    Expert Opin Ther Targets; 2024; 28(1-2):17-28. PubMed ID: 38234142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas.
    Kantidakis G; Litière S; Neven A; Vinches M; Judson I; Blay JY; Wardelmann E; Stacchiotti S; D'Ambrosio L; Marréaud S; van der Graaf WTA; Kasper B; Fiocco M; Gelderblom H
    Eur J Cancer; 2022 Oct; 174():261-276. PubMed ID: 36116829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Synovial Sarcoma and Myxoid Liposarcoma.
    Hindi N; Haas RL
    Surg Oncol Clin N Am; 2022 Jul; 31(3):547-558. PubMed ID: 35715149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
    Genevay M; Gengler C; Guillou L
    Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal changes in soft-tissue sarcomas. A new diagnostic parameter.
    Karakousis CP; Dal Cin P; Turc-Carel C; Limon J; Sandberg AA
    Arch Surg; 1987 Nov; 122(11):1257-60. PubMed ID: 2823744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
    Jacobs AJ; Morris CD; Levin AS
    Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma.
    He M; Abro B; Kaushal M; Chen L; Chen T; Gondim M; Yan W; Neidich J; Dehner LP; Pfeifer JD
    Hum Pathol; 2020 Jun; 100():15-23. PubMed ID: 32387103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
    Zhu MMT; Shenasa E; Nielsen TO
    Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft tissue sarcomas: From a morphological to a molecular biological approach.
    Oda Y; Yamamoto H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Bekki H
    Pathol Int; 2017 Sep; 67(9):435-446. PubMed ID: 28759137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in Sarcoma: Where Do Things Stand?
    Moreno Tellez C; Leyfman Y; D'Angelo SP; Wilky BA; Dufresne A
    Surg Oncol Clin N Am; 2022 Jul; 31(3):381-397. PubMed ID: 35715140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study.
    Hill DA; O'Sullivan MJ; Zhu X; Vollmer RT; Humphrey PA; Dehner LP; Pfeifer JD
    Am J Surg Pathol; 2002 Aug; 26(8):965-77. PubMed ID: 12170083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.
    Rao UN; Cieply K; Sherer C; Surti U; Gollin SM
    Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):168-177. PubMed ID: 26808135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
    van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
    PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Soft tissue sarcomas: clinical application of molecular biology].
    Chetaille B; Laibe S; Choukeir N; Bertucci F
    Rev Prat; 2013 Mar; 63(3):309-13. PubMed ID: 23687749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow involvement in adult soft tissue sarcomas.
    Bramwell VH; Littley MB; Chang J; Crowther D
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1099-106. PubMed ID: 6297916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.